Clene Inc. (CLNN) vs eXoZymes Inc. (EXOZ)

Clene Inc. and eXoZymes Inc. are both Biotechnology companies. Clene Inc. and eXoZymes Inc. are of similar size ($59.8M and $57.6M). eXoZymes Inc. has the higher net margin (0.00% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, eXoZymes Inc. leads on 7 and Clene Inc. on 4.

Valuation

Metric CLNN EXOZ Biotechnology median
P/E n/m n/m 7.88
P/S 270.29 n/m 11.47
P/B n/m 14.81 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 314.15 n/m 10.73
Earnings yield (81.40%) (19.04%) (28.84%)
Free cash flow yield (29.95%) (13.19%) (23.03%)

Profitability

Metric CLNN EXOZ Biotechnology median
Gross margin 70.05% — 65.16%
Operating margin (10,431.98%) 0.00% 0.00%
Net margin (20,059.90%) 0.00% 0.00%
Free cash flow margin (8,095.43%) 0.00% 0.00%
Return on equity 237.15% (187.16%) (57.72%)
Return on assets (174.99%) (115.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN EXOZ Biotechnology median
Revenue growth (TTM) (31.12%) — 5.64%
EPS growth (last fiscal year) 53.26% (22.47%) —
Revenue growth, 5-year CAGR (22.66%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CLNN EXOZ Biotechnology median
Debt to equity (0.74) 0.01 0.00
Current ratio 3.07 3.81 4.73
Net debt to EBITDA (0.39) 0.31 0.96

Dividend

Metric CLNN EXOZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CLNN EXOZ Biotechnology median
Market cap 59.84m 57.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack